SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Integrative Cancer Therapies
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lu, W.
Right arrow Articles by Rosenthal, D. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, W.
Right arrow Articles by Rosenthal, D. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Integrative Tumor Board: A Case Report and Discussion From Dana-Farber Cancer Institute

Weidong Lu

Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA

Mary Jane Ott

Dana-Farber Cancer Institute, Boston, MA, USA

Stacy Kennedy

Dana-Farber Cancer Institute, Boston, MA, USA, Brigham & Women's Hospital, Boston, MA, USA

Maria B. Mathay

Dana-Farber Cancer Institute, Boston, MA, USA

Anne M. Doherty-Gilman

Dana-Farber Cancer Institute, Boston, MA, USA

Elizabeth Dean-Clower

Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA

Carolyn M. Hayes

Dana-Farber Cancer Institute, Boston, MA, USA

David S. Rosenthal

Dana-Farber Cancer Institute, Boston, MA, USA, drose{at}uhs.harvard.edu, Harvard Medical School, Boston, MA, USA

A 34-year-old woman carrying a BRCA1 gene and a significant family history was diagnosed with T1c, N1 breast cancer. The tumor was estrogen receptor, progesterone receptor, and HER-2/Neu negative.The patient received dose-dense chemotherapy with Adriamycin and Cytoxan followed by Taxol, and left breast irradiation. Later, a bilateral S-GAP flap reconstruction with right prophylactic mastectomy and left mastectomy were performed. During her treatment, the patient had an integrative medicine consultation and was seen by a team of health care providers specializing in integrative therapies, including integrative nutrition, therapeutic massage, acupuncture, and yoga. Each modality contributed unique benefit in her care that led to a satisfactory outcome for the patient.A detailed discussion regarding her care from each modality is presented.The case elucidates the need for integrative approaches for cancer patients in a conventional medical setting.

Key Words: breast cancer • integrative oncology • acupuncture • massage • yoga • nutrition • exercise • case discussion • integrative medical consult • Dana-Farber • complementary therapies • integrative therapies

Integrative Cancer Therapies, Vol. 8, No. 3, 235-241 (2009)
DOI: 10.1177/1534735409343446


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement